Eliem Therapeutics, Inc. Stock Forecast
Explanation to Bollinger's Bands
Bollinger Bands was created by John Bollinger in the early 1980s, its purpose is to define price action relative to the assets highs and lows. This technical indicator is used to identify buy and sell signals and has proven very well in doing so.
Bollinger Bands consist of a set of three curves drawn in relation to securities prices. The middle band is a measure of the intermediate-term trend, usually a simple moving average, that serves as the base for the upper and lower bands. The interval between the upper and lower bands and the middle band is determined by volatility, typically the standard deviation of the same data that were used for the average. StockInvest.us uses Bollingers suggested 20 day average.
Middle Bollinger Band = 20-period simple moving average
Upper Bollinger Band = Middle Bollinger Band + 2 * 20-period standard deviation
Lower Bollinger Band = Middle Bollinger Band - 2 * 20-period standard deviation
BandWidth defines the current width of the band.
%b defines the current position within the band.
BandWidth = (Upper Bollinger Band - Lower Bollinger Band) / Middle Bollinger Band
%b = (Last - Lower Bollinger Band) / (Upper Bollinger Band - Lower Bollinger Band)
Live Samples:
Bottlenecks in bandwidth indicate an upcoming change. Break up through the moving average line or continuous movements above the moving average line indicate a break up, and vice versa.
Source: http://www.bollingerbands.com
Weaker technical forecast for Eliem Therapeutics, Inc. as stock downgraded to Sell Candidate.
(Updated on Jul 03, 2024)
The Eliem Therapeutics, Inc. stock price gained 0.734% on the last trading day (Wednesday, 3rd Jul 2024), rising from $6.81 to $6.86. During the last trading day the stock fluctuated 2.77% from a day low at $6.69 to a day high of $6.87. The price has fallen in 6 of the last 10 days and is down by -6.67% for this period. Volume fell on the last day by -8 thousand shares and in total, 85 thousand shares were bought and sold for approximately $585.57 thousand. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.
Given the current short-term trend, the stock is expected to rise 55.70% during the next 3 months and, with a 90% probability hold a price between $10.68 and $20.49 at the end of this 3-month period.
Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.
ELYM Signals & Forecast
There are few to no technical positive signals at the moment. The Eliem Therapeutics, Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $7.20 and $7.91. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Tuesday, May 07, 2024, and so far it has fallen -32.75%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell during the last trading day while the price increased. This causes a divergence and may be considered as an early warning, but it may also not.
Support, Risk & Stop-loss for Eliem Therapeutics, Inc. stock
Eliem Therapeutics, Inc. finds support from accumulated volume at $6.81 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
This stock may move much during the day (volatility) and with periodic low trading volume this stock is considered to be "high risk". During the last day, the stock moved $0.185 between high and low, or 2.77%. For the last week the stock has had daily average volatility of 10.29%.
Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.
Trading Expectations (ELYM) For The Upcoming Trading Day Of Friday 5th
For the upcoming trading day on Friday, 5th we expect Eliem Therapeutics, Inc. to open at $6.81, and during the day (based on 14 day Average True Range), to move between $6.06 and $7.66, which gives a possible trading interval of +/-$0.80 (+/-11.70%) up or down from last closing price. If Eliem Therapeutics, Inc. takes out the full calculated possible swing range there will be an estimated 23.40% move between the lowest and the highest trading price during the day.
Since the stock is closer to the support from accumulated volume at $6.81 (0.73%) than the resistance at $7.09 (3.35%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..
Is Eliem Therapeutics, Inc. stock A Buy?
The Eliem Therapeutics, Inc. stock holds several negative signals and despite the positive trend, we believe Eliem Therapeutics, Inc. will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Hold/Accumulate to a Sell candidate.
Current score: -4.472 Sell Candidate Downgraded
Predicted Opening Price for Eliem Therapeutics, Inc. of Friday, July 5, 2024
| Fair opening price July 5, 2024 | Current price |
|---|---|
| $6.81 ( 0.80%) | $6.86 |
The predicted opening price is based on yesterday's movements between high, low, and closing price.
Trading levels for ELYM
Fibonacci Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 6.99 | 1.90% |
| R2 | 6.92 | 0.86% |
| R1 | 6.88 | 0.228% |
| Price | 6.86 | |
| S1 | 6.73 | -1.83% |
| S2 | 6.69 | -2.47% |
| S3 | 6.62 | -3.50% |
Accumulated Volume Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 7.57 | 10.35% |
| R2 | 7.11 | 3.64% |
| R1 | 7.09 | 3.35% |
| Price | 6.86 | |
| S1 | 6.81 | -0.729% |
| S2 | 0 | - |
| S3 | 0 | - |
FAQ
Click here for our free guide on how to buy Eliem Therapeutics, Inc. Stock.
